<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Khananshvili D</submitter><funding>Israeli Science Foundation</funding><funding>Israel Science Foundation</funding><pagination>61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9820601</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>The plasma-membrane homeostasis Na&lt;sup>+&lt;/sup>/Ca&lt;sup>2+&lt;/sup> exchangers (NCXs) mediate Ca&lt;sup>2+&lt;/sup> extrusion/entry to dynamically shape Ca&lt;sup>2+&lt;/sup> signaling/in biological systems ranging from bacteria to humans. The NCX gene orthologs, isoforms, and their splice variants are expressed in a tissue-specific manner and exhibit nearly 10&lt;sup>4&lt;/sup>-fold differences in the transport rates and regulatory specificities to match the cell-specific requirements. Selective pharmacological targeting of NCX variants could benefit many clinical applications, although this intervention remains challenging, mainly because a full-size structure of eukaryotic NCX is unavailable. The crystal structure of the archaeal NCX_Mj, in conjunction with biophysical, computational, and functional analyses,</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Structure-Based Function and Regulation of NCX Variants: Updates and Challenges.</pubmed_title><pmcid>PMC9820601</pmcid><funding_grant_id>1351/18</funding_grant_id><funding_grant_id>852/14</funding_grant_id><pubmed_authors>Khananshvili D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structure-Based Function and Regulation of NCX Variants: Updates and Challenges.</name><description>The plasma-membrane homeostasis Na&lt;sup>+&lt;/sup>/Ca&lt;sup>2+&lt;/sup> exchangers (NCXs) mediate Ca&lt;sup>2+&lt;/sup> extrusion/entry to dynamically shape Ca&lt;sup>2+&lt;/sup> signaling/in biological systems ranging from bacteria to humans. The NCX gene orthologs, isoforms, and their splice variants are expressed in a tissue-specific manner and exhibit nearly 10&lt;sup>4&lt;/sup>-fold differences in the transport rates and regulatory specificities to match the cell-specific requirements. Selective pharmacological targeting of NCX variants could benefit many clinical applications, although this intervention remains challenging, mainly because a full-size structure of eukaryotic NCX is unavailable. The crystal structure of the archaeal NCX_Mj, in conjunction with biophysical, computational, and functional analyses,</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-06-01T02:35:27.476Z</modification><creation>2024-11-15T07:49:40.776Z</creation></dates><accession>S-EPMC9820601</accession><cross_references><pubmed>36613523</pubmed><doi>10.3390/ijms24010061</doi></cross_references></HashMap>